Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical pharmacology study of pemafibrate controlled-release tablet
jRCT2080224854Phase 2Completed
- Sponsor
- Kowa Company, Ltd.
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of pemafibrate in dyslipidemia and hypertriglyceridemia (2 arms), sponsored by Kowa Company, Ltd. Primary endpoint: Pharmacokinetic profile of pemafibrate CR vs IR. Started Sep 2019; status: completed.
02
Drugs
pemafibrate
03
Conditions
dyslipidemiahypertriglyceridemia
Beyond the preview
Go deeper on jRCT2080224854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224854.